Zenpep Market Report 2026

Zenpep Market Overview

• The Zenpep market growth in the historic period has been driven by increasing prevalence of cystic fibrosis, advancement of pancrelipase formulations • Market expansion is supported by increasing demand for long-term digestive support therapies, rising focus on personalized dosing regimens • Growth Driver: Rising Prevalence Of Pancreatic Disorders Driving Growth In The Market • North America was the largest region in 2025.

What Is Covered Under Zenpep Market?

Zenpep (pancrelipase) is a prescription medication used to treat exocrine pancreatic insufficiency (EPI) due to conditions such as cystic fibrosis, chronic pancreatitis, or other pancreatic disorders. It contains a combination of digestive enzymes (lipase, protease, and amylase) that aid in the digestion of fats, proteins, and carbohydrates, improving nutrient absorption. The main indications of zenpep are cystic fibrosis, chronic pancreatitis, pancreatic cancer, and post-surgical patients. Cystic fibrosis is a hereditary condition characterized by the accumulation of thick, sticky mucus, which results in respiratory and digestive issues, including a lack of pancreatic enzymes. It is distributed through several distribution channels, such as hospital pharmacies, retail pharmacies, and online pharmacies, and is used by various end users, including adults, geriatrics, and pediatrics.

What Is The Zenpep Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for long-term digestive support therapies, rising focus on personalized dosing regimens, expansion of pediatric and adult epi treatment access, growing specialty pharmacy distribution, innovation in enzyme delivery technologies. Major trends in the forecast period include expansion of enzyme replacement therapy utilization, increasing diagnosis of exocrine pancreatic insufficiency, growing focus on digestive disorder management, enhanced formulation stability improvements, rising patient adherence programs.

Global Zenpep Market Segmentation

1) By Indication: Cystic Fibrosis, Chronic Pancreatitis, Pancreatic Cancer, Post-Surgical Patients 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By End-User: Adult, Geriatric, Pediatric

What Are The Drivers Of The Zenpep Market?

The increasing prevalence of pancreatic disorders is expected to propel the growth of the zenpep market going forward. Pancreatic disorders encompass various conditions that impact the pancreas, such as inflammation, cancer, and enzyme imbalances, impairing its role in regulating blood sugar and supporting digestion. The prevalence of pancreatic disorders is rising due to factors such as increasing rates of obesity, unhealthy diets, high alcohol consumption, smoking, and genetic predispositions. Zenpep offers pancreatic enzyme replacement therapy (PERT) with enzymes to help break down fats, carbohydrates, and proteins. It aids individuals with pancreatic insufficiency in digesting food and absorbing nutrients, relieving symptoms such as malnutrition and digestive discomfort. For instance, in August 2024, according to a report published by NHS England, a UK-based government agency, cystic fibrosis is a prevalent, life-limiting, recessively inherited condition in the UK, affecting around 9,259 people in England compared to 11,148 people across the entire UK. Therefore, the increasing prevalence of pancreatic disorders is driving the growth of the zenpep industry. The growing awareness of gastrointestinal disorders is significantly driving the growth of the zenpep market in the future. Gastrointestinal disorders are conditions impacting the digestive system, including the stomach and intestines, causing symptoms such as pain, bloating, and digestive disturbances. Awareness of gastrointestinal disorders is rising due to factors such as increased gastrointestinal disorder prevalence, advancements in diagnostic technologies, improved patient education, and heightened focus on digestive health in public health initiatives. Zenpep is used to manage certain gastrointestinal disorders and contains a blend of pancreatic enzymes. These enzymes assist in breaking down and absorbing nutrients from food, supporting proper digestion. For instance, in April 2024, according to a report published by the ME Association, a UK-based charitable organization, approximately 10 to 15% of the population experiences irritable bowel syndrome, making it one of the most prevalent gastrointestinal disorders. Furthermore, between 35% and 70% of individuals with fibromyalgia also suffer from irritable bowel syndrome. Therefore, the growing awareness of gastrointestinal disorders is driving the growth of the zenpep industry. The growing aging population is set to propel growth of the zenpep market moving forward. An aging population is a demographic shift characterized by a growing percentage of individuals aged 60 or 65 and above within a population. The growing aging population is driven by factors such as declining fertility rates, increased life expectancy, social services, and economic structures to better support and engage this demographic. As people age, the production of digestive enzymes decreases, causing nutrient malabsorption. Zenpep supplements these enzymes, improving nutrient absorption and digestive health. For instance, in January 2024, according to the Population Reference Bureau, a Kenya-based nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group’s share of the overall population is also projected to rise from 17% to 23% during the same period. Therefore, the growing aging population is driving the growth of the zaltrap market.

Key Players In The Global Zenpep Market

Major companies operating in the zenpep market are Nestle Health Science S.A.

Regional Insights

North America was the largest region in the zenpep market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Zenpep Market?

The zenpep market consists of sales of capsules, granules, and powder for oral solution. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Zenpep Market Report 2026?

The zenpep market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the zenpep industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.